RAFFERTY ASSET MANAGEMENT, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$17.07M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +21.98% | 4.46K shares | 5.06M | $688.87 | 24.79K |
| Q2 2022 | share | Decrease | -4.23% | -897 shares | -2.80M | $591.13 | 20.32K |
| Q1 2022 | share | Increase | +17.34% | 3.13K shares | 3.4M | $698.42 | 21.22K |
| Q4 2021 | share | Increase | +23.89% | 3.48K shares | 2.58M | $642.51 | 18.08K |
| Q3 2021 | share | Increase | +4.77% | 665 shares | 1.05M | $605.18 | 14.59K |
| Q2 2021 | share | Decrease | -16.19% | -2.69K shares | -83K | $558.54 | 13.93K |
| Q1 2021 | share | Increase | +48.98% | 5.46K shares | 2.47M | $473.14 | 16.62K |
| Q4 2020 | share | Increase | +4.66% | 497 shares | -577K | $483.11 | 11.15K |
| Q3 2020 | share | Increase | +19.08% | 1.70K shares | 384K | $559.78 | 10.66K |
| Q2 2020 | share | Increase | +8.92% | 733 shares | 1.57M | $623.65 | 8.95K |
| Q1 2020 | share | Decrease | -58.62% | -11.64K shares | -3.44M | $488.29 | 8.22K |
| Q4 2019 | share | Decrease | -34.55% | -10.48K shares | -961K | $375.48 | 19.86K |
| Q3 2019 | share | Increase | +25.44% | 6.15K shares | 847K | $277.4 | 30.35K |
| Q2 2019 | share | Increase | +38.37% | 6.71K shares | 393K | $313 | 24.19K |
| Q1 2019 | share | Increase | +283.28% | 12.92K shares | 5.47M | $410.62 | 17.48K |
| Q4 2018 | share | Decrease | -14.93% | -801 shares | -463K | $373.5 | 4.56K |
| Q3 2018 | share | Decrease | -0.74% | -40 shares | 303K | $404.04 | 5.36K |
| Q2 2018 | share | Increase | +8.67% | 431 shares | 151K | $344.99 | 5.40K |
| Q1 2018 | share | Increase | +31.32% | 1.18K shares | 289K | $344.36 | 4.97K |
| Q4 2017 | share | Decrease | -26.02% | -1.33K shares | -865K | $375.96 | 3.78K |
| Q3 2017 | share | Increase | +64.55% | 2.00K shares | 761K | $447.12 | 5.11K |
| Q2 2017 | share | Increase | +2.88% | 87 shares | 356K | $491.14 | 3.11K |
| Q1 2017 | share | Increase | +13.77% | 366 shares | 196K | $387.51 | 3.02K |
| Q4 2016 | share | Increase | +47.91% | 861 shares | 254K | $367.09 | 2.65K |
| Q3 2016 | share | Increase | +8.32% | 138 shares | 143K | $402.02 | 1.79K |
| Q2 2016 | share | Decrease | -50.30% | -1.67K shares | -624K | $349.23 | 1.65K |
| Q1 2016 | share | Decrease | -20.26% | -848 shares | -1.09M | $360.44 | 3.33K |